Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Microbiology

  • Subscribe to feed (RSS)

Showing page 124 of 255 pages of list content

  • An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens

    This article's authors
    1. Pragya D. Yadav
    2. Nivedita Gupta
    3. Varsha Potdar
    4. Sreelekshmy Mohandas
    5. Rima R. Sahay
    6. Prasad Sarkale
    7. Anita M. Shete
    8. Alpana Razdan
    9. Deepak Y. Patil
    10. Dimpal A. Nyayanit
    11. Yash Joshi
    12. Savita Patil
    13. Triparna Majumdar
    14. Hitesh Dighe
    15. Bharti Malhotra
    16. Jayanthi Shastri
    17. Priya Abraham
    This article has 1 evaluations Latest evaluation on Jan 6, 2022 Published on Jan 3, 2022
  • The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein

    This article's authors
    1. Thomas P. Peacock
    2. Jonathan C. Brown
    3. Jie Zhou
    4. Nazia Thakur
    5. Ksenia Sukhova
    6. Joseph Newman
    7. Ruthiran Kugathasan
    8. Ada W.C. Yan
    9. Wilhelm Furnon
    10. Giuditta De Lorenzo
    11. Vanessa M. Cowton
    12. Dorothee Reuss
    13. Maya Moshe
    14. Jessica L. Quantrill
    15. Olivia K. Platt
    16. Myrsini Kaforou
    17. Arvind H. Patel
    18. Massimo Palmarini
    19. Dalan Bailey
    20. Wendy S. Barclay
    This article has 1 evaluations Latest evaluation on Jan 6, 2022 Published on May 13, 2022
  • Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters

    This article's authors
    1. Katherine McMahan
    2. Victoria Giffin
    3. Lisa H. Tostanoski
    4. Benjamin Chung
    5. Mazuba Siamatu
    6. Mehul S. Suthar
    7. Peter Halfmann
    8. Yoshihiro Kawaoka
    9. Cesar Piedra-Mora
    10. Amanda J. Martinot
    11. Swagata Kar
    12. Hanne Andersen
    13. Mark G. Lewis
    14. Dan H. Barouch
    This article has 1 evaluations Latest evaluation on Jan 6, 2022 Published on Jan 3, 2022
  • Subgenomic SARS-CoV-2 replicon and reporter replicon cell lines enable ultrahigh throughput antiviral screening and mechanistic studies with antivirals, viral mutations or host factors that affect COVID-19 replication

    This article's authors
    1. Shuiyun Lan
    2. Philip R. Tedbury
    3. Yee Tsuey Ong
    4. Raven Shah
    5. Ryan L. Slack
    6. Maria E. Cilento
    7. Huanchun Zhang
    8. Haijuan Du
    9. Nicole Lulkin
    10. Uyen Le
    11. Karen A. Kirby
    12. Ivo Melcak
    13. William A. Cantara
    14. Emerson A. Boggs
    15. Stefan G. Sarafianos
    This article has 1 evaluations Latest evaluation on Jan 4, 2022 Published on Dec 30, 2021
  • SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19

    This article's authors
    1. Eleanor G. Bentley
    2. Adam Kirby
    3. Parul Sharma
    4. Anja Kipar
    5. Daniele F. Mega
    6. Chloe Bramwell
    7. Rebekah Penrice-Randal
    8. Tessa Prince
    9. Jonathan C. Brown
    10. Jie Zhou
    11. Gavin R. Screaton
    12. Wendy S. Barclay
    13. Andrew Owen
    14. Julian A. Hiscox
    15. James P. Stewart
    This article has 1 evaluations Latest evaluation on Jan 3, 2022 Published on Dec 30, 2021
  • Intranasal inhibitor broadly blocks SARS-CoV-2 including recent highly immunoevasive Omicron subvariants

    This article's authors
    1. Anna R. Mäkelä
    2. Hasan UÄŸurlu
    3. Liina Hannula
    4. Ravi Kant
    5. Petja Salminen
    6. Riku Fagerlund
    7. Sanna Mäki
    8. Anu Haveri
    9. Tomas Strandin
    10. Lauri Kareinen
    11. Jussi Hepojoki
    12. Suvi Kuivanen
    13. Lev Levanov
    14. Arja Pasternack
    15. Rauno A. Naves
    16. Olli Ritvos
    17. Pamela Österlund
    18. Tarja Sironen
    19. Olli Vapalahti
    20. Anja Kipar
    21. Juha T. Huiskonen
    22. Ilona Rissanen
    23. Kalle Saksela
    This article has 1 evaluations Latest evaluation on Jan 3, 2022 Published on Dec 29, 2022
  • Effect of nebulised BromAc ® on rheology of artificial sputum: relevance to muco-obstructive respiratory diseases including COVID-19

    This article's authors
    1. Krishna Pillai
    2. Ahmed H. Mekkawy
    3. Javed Akhter
    4. Sarah J. Valle
    5. David L. Morris
    This article has 1 evaluations Latest evaluation on Jan 3, 2022 Published on Dec 28, 2021
  • SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster

    This article's authors
    1. Sabrina Lusvarghi
    2. Simon D. Pollett
    3. Sabari Nath Neerukonda
    4. Wei Wang
    5. Richard Wang
    6. Russell Vassell
    7. Nusrat J. Epsi
    8. Anthony C Fries
    9. Brian K Agan
    10. David A. Lindholm
    11. Christopher J. Colombo
    12. Rupal Mody
    13. Evan C. Ewers
    14. Tahaniyat Lalani
    15. Anuradha Ganesan
    16. Emilie Goguet
    17. Monique Hollis-Perry
    18. Si’Ana A. Coggins
    19. Mark P. Simons
    20. Leah C. Katzelnick
    21. Gregory Wang
    22. David R. Tribble
    23. Lisa Bentley
    24. Ann E. Eakin
    25. Christopher C. Broder
    26. Karl J. Erlandson
    27. Eric D. Laing
    28. Timothy H. Burgess
    29. Edward Mitre
    30. Carol D. Weiss
    This article has 1 evaluations Latest evaluation on Jan 3, 2022 Published on Dec 28, 2021
  • Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

    This article's authors
    1. Laura Vangeel
    2. Winston Chiu
    3. Steven De Jonghe
    4. Piet Maes
    5. Bram Slechten
    6. Joren Raymenants
    7. Emmanuel André
    8. Pieter Leyssen
    9. Johan Neyts
    10. Dirk Jochmans
    This article has 1 evaluations Latest evaluation on Jan 3, 2022 Published on Jan 15, 2022
  • Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529

    This article's authors
    1. Qian Wang
    2. Saumya Anang
    3. Sho Iketani
    4. Yicheng Guo
    5. Lihong Liu
    6. David D. Ho
    7. Joseph G. Sodroski
    This article has 1 evaluations Latest evaluation on Jan 3, 2022 Published on Dec 29, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information